MedKoo Cat#: 145290 | Name: Etaden

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Etaden is shown to have active influence on protein synthesis, which favors more rapid regression of ulcerous defect.

Chemical Structure

Etaden
Etaden
CAS#66813-29-4

Theoretical Analysis

MedKoo Cat#: 145290

Name: Etaden

CAS#: 66813-29-4

Chemical Formula: C7H10N6O

Exact Mass: 194.0916

Molecular Weight: 194.20

Elemental Analysis: C, 43.29; H, 5.19; N, 43.28; O, 8.24

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Etaden; Ethaden;
IUPAC/Chemical Name
2-((6-amino-7H-purin-8-yl)amino)ethan-1-ol
InChi Key
CRWIVQWPUFWSCJ-UHFFFAOYSA-N
InChi Code
1S/C7H10N6O/c8-5-4-6(11-3-10-5)13-7(12-4)9-1-2-14/h3,14H,1-2H2,(H4,8,9,10,11,12,13)
SMILES Code
NC1=C2NC(NCCO)=NC2=NC=N1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 194.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Stepaniuk GI, Ornostaĭ VV, Kozlov VG. Sravnitel'naia otsenka ranozazhivliaiushchego deĭstviia benzofurokaina, étadena i ksantinola nikotinata v éksperimente [Comparative evaluation of the wound-healing effect of benzofuracaine, etaden, and xanthinol nicotinate in an experiment]. Patol Fiziol Eksp Ter. 1992 May-Jun;(3):16-8. Russian. PMID: 1480413. 2: Kuzina VA, Rusanov AM, Gavrilov RI. Vliianiw étadena na fermentativnuiu aktivnost' kishechnika u obluchennykh krys [Effect of etaden on intestinal enzymatic activity in irradiated rats]. Med Radiol (Mosk). 1978 May;23(3):69-71. Russian. PMID: 642738. 3: Korepanov AM, Murashov VS, Bazhenov EL. Dinamika nekotorykh pokazateleĭ belkovo-metabolicheskogo gomeostaza i sostoianie regeneratsii duodenal'noĭ slizistoĭ v protsesse lecheniia iazvnenoĭ bolezni dvenadtsatiperstnoĭ kishki étadenom [The dynamics of the indices of protein metabolic homeostasis and the status of duodenal mucosal regeneration during the etaden treatment of duodenal peptic ulcer]. Ter Arkh. 1992;64(2):52-5. Russian. PMID: 1509384. 4: Ornostaĭ VV, Stepaniuk GI. Vliianie benzofurokaina, étadena i ksantinola nikotinata na reparativnuiu regeneratsiiu kosteĭ v éksperimente [Effects of benzofurocaine, etaden and xanthinol nicotinate on reparative bone regeneration in animal experiments]. Ortop Travmatol Protez. 1991 Jul;(7):36-8. Russian. PMID: 1762734. 5: Kan Ch, Karimova RIa, Kravchenko LIa, Saidmuradova A. Lechenie trudnozazhivaiushchikh khronicheskikh iazv zheludka putem vvedeniia étadena v podslizistuiu obolochku organa [Treatment of non-healing chronic stomach ulcers by administration of etaden into the gastric submucosal layer]. Ter Arkh. 1988;60(1):83-6. Russian. PMID: 3363516. 6: Spivak AM, Reĭngardt BK, Korneĭchuk AV, Sorokina GK. Primenenie étadena u bol'nykh iazvennoĭ bolezh'iu [The use of etaden in patients with peptic ulcer]. Vrach Delo. 1988 Apr;(4):25-7. Russian. PMID: 3041676. 7: Gabelov AA, Nazyrova FA, Larionova LP, Rusanov AM, Novoselova GS. Lechenie mestnykh luchevykh povrezhdenii étadenom [Treatment of local radiation injuries with etaden]. Med Radiol (Mosk). 1977 Feb;22(2):52-6. Russian. PMID: 323630. 8: Rusanov AM, Novoselova GS, Smirnova GA. Lechenie étadenom éksperimental'noĭ luchevoĭ leĭkopenii [Treatment of experimental radiation leukopenia with Etaden]. Med Radiol (Mosk). 1967 Jul;12(7):79-80. Russian. PMID: 5603437. 9: Korepanov AM, Murashov VS, Martynov GN. Kompleksnaia kliniko- immunologicheskaia otsenka éffektivnosti étadena pri iazvennoĭ bolezni dvenadtsatiperstnoĭ kishki [Complex clinico-immunologic assessment of the efficacy of ethadene in treating duodenal ulcers]. Klin Med (Mosk). 1989 Jul;67(7):58-61. Russian. PMID: 2811217. 10: Kibrik BS, Krylova GO. Primenenie étadena v kompleksnom lechenii vpervye vyiavlennykh bol'nykh infil'trativnym tuberkulezom legkikh [The use of ethaden in the complex treatment of newly diagnosed patients with infiltrative tuberculosis of the lungs]. Probl Tuberk. 1990;(5):36-40. Russian. PMID: 2388891.